OFLX
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 54 | +4 | 2.43M | $76.28M | +4 | — |
| Q1 2026 | 52 | -1 | 2.39M | $74.30M | +2 | −3 |
| Q4 2025 | 53 | +3 | 2.52M | $74.28M | +3 | — |
| Q3 2025 | 14 | -1 | 1.11M | $34.79M | — | −1 |
| Q2 2025 | 12 | +1 | 834.95K | $27.06M | +1 | — |
| Q1 2025 | 8 | 0 | 370.75K | $12.90M | — | — |
| Q4 2024 | 8 | 0 | 329.45K | $13.85M | — | — |
| Q3 2024 | 7 | 0 | 281.42K | $14.05M | — | — |
| Q2 2024 | 7 | — | 258.33K | $13.25M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 87.00K | — | $4.46M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Millennium Management ✦ | 40.76K | — | $2.09M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 37.70K | — | $1.93M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 35.23K | — | $1.81M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 5 | Two Sigma Investments ✦ | 25.42K | — | $1.30M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Marshall Wace ✦ | 20.76K | — | $1.06M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 11.47K | — | $588,182 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 107 holders, 2.97M shares, $88.90M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer, Director · President · 790 sh @ 25.43 · $20,090
Officer · Vice President - CFO · 1.00K sh @ 25.42 · $25,420
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology